semaglutide injection needles Injections Understanding Semaglutide Maximum Dose for

This study population was then divided into 3 cohorts: (1) semaglutide cohort 45,797 patients who were first-time prescribed semaglutide, (2) non-GLP1-RA anti-obesity medication cohort 38,028 patients who were first-time prescribed non-GLP-1RA anti-obesity medications but not semaglutide and (3) naltrexone/topiramate cohort 16,676 patients who were first time prescribed naltrexone and topiramate but not semaglutide

SWOT analysis indicates that nearly 68% of strengths are associated with clinical effectiveness and patient outcomes, while 42% of weaknesses relate to accessibility and treatment complexity

PHOTO: GLP-1s are widely prescribed for weight loss

Acknowledgments This work was supported by the Brazilian research funding agencies FAPERGS (PqG 1008860, PqG 1008857, ARD11/1893-7, and PRONEX 1000274), CAPES (PROCAD 066/2007), CNPq, PROPESQ-UFRGS, and IBN-Net no